Skip to content
Open access

Peripheral neurotransmitter metabolic signatures in schizophrenia: a targeted metabolomics study

Sep 2026 · Frontiers in Psychiatry · Vol 17 · 0 citations · 29 references
Medicine

TL;DR

The four-metabolite panel (α-ketoglutarate, succinic acid, tryptamine, and amino butyric acid) may provide experimental basis for further mechanistic research and therapeutic development and offer peripheral evidence supporting the core position of GABAergic dysfunction in schizophrenia.

Abstract

Objective To investigate peripheral metabolic alterations in patients with schizophrenia using a two-stage metabolomic workflow of untargeted analysis and targeted re-analysis,explore the associated metabolic pathways, identify potential peripheral metabolic biomarkers, and elucidate the underlying metabolic dysregulation mechanisms. Methods Plasma samples were collected from 24 schizophrenia patients and 10 healthy controls for non-derivatized targeted metabolomics analysis. Differential metabolites were identified and visualized using box plots. Hierarchical clustering analysis was performed to evaluate expression pattern differences across samples, and KEGG pathway enrichment analysis was conducted to map the involved biological pathways. False discovery rate (FDR) correction was applied for multiple comparisons. Results Among the 21 quantified metabolites, four exhibited significant differences after FDR correction (FDR < 0.05). α-Ketoglutarate was significantly elevated in the patient group, whereas succinic acid, tryptamine, and amino butyric acid were significantly reduced. The opposite variations of α-ketoglutarate and succinic acid suggest a peripheral TCA cycle metabolic bottleneck. Hierarchical clustering based on these four metabolites effectively distinguished patients from healthy controls. KEGG enrichment demonstrated that these metabolites converged predominantly on amino acid metabolism, energy metabolism, and most notably the GABAergic synapse pathway, offering peripheral evidence supporting the core position of GABAergic dysfunction in schizophrenia. Conclusion Schizophrenia patients display significant peripheral metabolic disturbances characterized by dysregulated amino acid metabolism, synaptic transmission abnormalities, and energy metabolism imbalance. The four-metabolite panel (α-ketoglutarate, succinic acid, tryptamine, and amino butyric acid) may provide experimental basis for further mechanistic research and therapeutic development.

Read PDF

Similar papers

Open access Sep 2026

Exploring metabolic candidates and inflammatory mediation in Parkinson’s disease: a pilot integrative metabolomics and Mendelian randomization study

This exploratory study integrates pilot-scale metabolomics with genetic analyses to identify candidate metabolic signals and inflammatory pathways linked to PD and indicated that SULT1A1 may partially mediate the association between 3-phenylpropionylglycine and PD.

Yue Lang, Hui Zhang, Rui Feng et al. · 0 citations
Open access Aug 2026

Amino acid- and lipid-related metabolic remodeling in PTZ-kindled mice reveals candidate plasma signatures of chronic epilepsy

PTZ-induced kindling was associated with marked plasma metabolic alterations involving amino acid-, tryptophan-, and lipid-related pathways, which supports the broader relevance of metabolic dysregulation to epilepsy, while the mechanistic roles and biomarker potential of individual metabolites require independent vali...

Juan Ren, Fu-Li Wang, Zi-Jian Li et al. · 0 citations
Open access Sep 2026

Untargeted plasma metabolomics reveals systemic metabolic dysregulation and reatment-associated metabolic modulation following YWKS treatment in sleep disorder patients

Sleep disorders are common and significantly impact metabolic regulation, but the overarching blood metabolomic characteristics and how drugs for these disorders affect metabolism have not been adequately described. Blood plasma from three distinct cohorts-healthy individuals, sleep disorder patients (SDP), and those u...

Anwar Abdurahman, Ailiyaer Yasheng, Aikelidan Abulajiang et al. · 0 citations
Open access Sep 2026

Metabolic differences among patients with alcohol-related liver disease using targeted and untargeted metabolomics techniques

Serum levels of five DEMs (Glu, Pro, Orn, Cit, Cit, and Arg) are closely linked to ALD-related metabolic dysregulation; they serve as potential indicators of ALD progression and provide valuable insights for the clinical staging and targeted intervention of ALD.

Jie-Sen Lu, Li Zhao, Tian-Yi Zhu et al. · 0 citations
Open access Aug 2026

Untargeted metabolomics reveals differential metabolic pathways and biomarkers in the acute phase of Kawasaki disease

Untargeted metabolomics enables identification of metabolically perturbed pathways during the acute phase of KD, and L-tyrosine, L-tryptophan, glutamine, histidine, histamine, and taurocholic acid may serve as candidate biomarkers for acute phase of KD.

Han-Qi Dai, Qian-Wen Wang, Yi Zhan · 0 citations
Open access Sep 2026

Hepato-Immune Crosstalk Underlies Antipsychotic-Associated Metabolic Dysregulation in Schizophrenia: Quercetin as a Therapeutic Candidate for High-Inflammatory Subtypes

Background: Patients with schizophrenia (SCZ) receiving antipsychotic treatment frequently develop metabolic complications, yet the mechanisms underlying liver-immune crosstalk remain poorly characterized. Methods: This study recruited 340 antipsychotic-treated SCZ patients and 340 matched healthy controls, with a 2-ye...

Yi Yang, Bin Liu, Zhi-Cheng Cao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.